Imaging of the Fetal Face and Neck


Cleft Lip and Palate

Definition

  • Cleft lip: failure of fusion of the left, right, or bilateral maxillary prominence with the medial nasal prominence. Concomitant cleft palate is present in 80% of cases. Least severe form involves the superficial vermilion border of the lip.

  • Cleft palate: a result of incomplete fusion of the lateral palatal shelves, the nasal septum, and the primary palate. The cleft can be unilateral or bilateral. Least severe form is a bifid uvula.

  • Clefts associated with hypo- or hypertelorism have an increased association with brain anomalies. ,

  • Hypotelorism and holoprosencephaly.

  • Hypertelorism and dysgenesis of the corpus callosum and pituitary abnormalities.

  • Clefts can be isolated defects or appear as part of a syndrome. Various genetic and environmental factors contribute to developmental risk. , ,

  • Can be divided into the following types

    • Unilateral cleft lip (CL) with cleft palate (CP) (most common)

    • Unilateral CL without CP

    • Bilateral CL and CP

    • Midline CL and CP

    • Isolated CP

Incidence and Pathogenesis

  • Incidence of CL with CP is approximately 1:700 live births and varies by geographic, racial, and ethnic groups; socioeconomic status; and environmental exposure.

    • Asian and Native American populations: 1:500

    • African populations: 1:2500

    • Non-Hispanic White and Hispanic populations: 1:1000

  • Variation between sex and laterality , ,

    • CL±CP 2:1 male-to-female ratio

    • CP 2:1 female-to-male ratio

    • Cleft location 2:1 left-to-right ratio

  • Genetics and associated anomalies

    • CL±CP is associated with a genetic syndrome in 30% of cases.

    • Isolated CP is associated with a genetic syndrome in 50% of cases.

    • Additional anomaly present in 30% of CL±CP.

  • Embryology ,

    • Upper lip and primary palate normally fuse by week 7.

    • Secondary palate forms by fusion of palatal shelf by week 12.

  • CL or CP occurs if the frontonasal process of the face does not join the lateral maxillary prominences at about week 7. , , ,

  • Normally developing fetal brain induces frontonasal development. Abnormality in the underlying brain can be associated with a midline facial cleft by week 4. , ,

  • Environmental risk factors ,

    • Smoking, alcohol, organic solvents, agricultural chemicals, folate and zinc deficiencies, retinoids, and anticonvulsant drugs.

Key Diagnostic Features

  • Ultrasound can visualize beginning at 13–14 weeks of gestation but is less sensitive in detecting CL±CP prior to 18–20 weeks. , The presence of additional anomalies increases detection rates.

  • Lips are best seen in coronal view; palate is best visualized from axial view. Three-dimensional ultrasound can help. , ,

  • Unilateral CL±CP

    • Left-sided more common.

    • Obliquely aligned gap in the lip extends to the nose.

    • Profile view may demonstrate a hooked nose.

    • A gap between the maxilla and palate may be present.

  • Bilateral CL±CP

    • Central mass protrudes below the nose.

    • Profile view may show an infranasal, premaxillary mass.

    • Standard view of the lips may be difficult to obtain.

    • If anterior palate is involved, a gap in the alveolar ridge of the maxilla may be visualized.

  • Midline CL and CP

    • Absent central maxilla and upper lip.

    • Deformed nose, possibly even absent and replaced by a proboscis. The nose may be small or have a single nostril.

  • Three-dimensional ultrasound may demonstrate the interior of the mouth better, enabling better visualization of the fetal palate; alveolar ridge disruption or premaxillary protrusion suggests presence of bilateral CL and CP. Better assessment of the posterior palate is also possible. , ,

  • The amniotic fluid and placenta are usually unaffected. However, if swallowing is affected by CL or CP, polyhydramnios may result.

  • When CL±CP is isolated, fetal growth is typically unaffected.

Differential Diagnosis

  • Amniotic band syndrome (especially when the clefting does not follow embryonic developmental pathways)

  • Facial mass

    • Nasal/oral teratoma (epignathus)

    • Anterior meningocele

    • Frontal encephalocele

    • Hemangioma/lymphangioma

    • Lymphangioma

    • Proboscis

    • Rhabdomyosarcoma

    • Macroglossia

  • Frontonasal dysplasia

  • Premaxillary agenesis, associated with holoprosencephaly

  • Normal variant with delayed maxillary fusion

  • More than 500 syndromes are associated with facial clefting, , , including trisomy 13 and 18, Treacher Collins, Pierre Robin, Goldenhar, DiGeorge, Crouzon, Van der Woude, and Waardenburg. , ,

Associated Anomalies

  • Lumbar and cervical spine (33%)

  • Cardiac (24%)

  • Chromosomal (10%), especially trisomy 13 7,8

  • Polyhydramnios if defective swallowing

  • Central CL or CP is typically associated with other facial findings, such as hypotelorism or cyclops. In this setting, there is increased incidence of holoprosencephaly and trisomy 13.

  • Other associated syndromes include frontonasal dysplasia and premaxillary agenesis, which typically is associated with alobar holoprosencephaly.

Imaging

Figure 21.1, Cleft lip (arrow).

Figure 21.2, Large lateral cleft lip and palate.

Figure 21.3, Midline cleft lip.

Figure 21.4, Large midline cleft lip (arrow).

Figure 21.5, Midline cleft lip.

Figure 21.6, Unilateral cleft lip (arrow).

Management

Antenatal Monitoring

  • Antenatal studies and consultations to offer:

    • Prenatal genetics consultation

    • Diagnostic testing of fetal chromosomal microarray via chorionic villus sampling or amniocentesis

    • Consider whole exome gene sequencing with gene panels designed for diagnostic testing of syndromic cleft lip and/or palate when there is at least third-degree family history of oral clefting

    • Fetal echocardiogram

    • Neonatology consultation

    • Pediatric craniofacial consultation

  • Consider ultrasound follow-up due to risk for other anomalies and growth disturbances.

  • Supplementation: folic acid (4 mg daily) before any future conception.

Obstetric Management

  • The intrapartum course is typically unaffected.

  • Because of the potential for difficulties that may arise in securing the airway of a neonate with CL or CP, delivery at a facility with experience in this is recommended. (This is not necessary for neonates who are believed to have simple clefts and can be delivered wherever planned.)

Neonatal Management

  • Pediatric team present at time of delivery to assess neonatal airway and well-being.

  • Examination by a pediatric dysmorphologist. In up to 25% of infants with orofacial clefting, an associated malformation is discovered postnatally.

  • Timing of repair depends on the nature of anatomic malformation. ,

    • CL usually repaired at 2–3 months. ,

    • CP usually repaired at 9–18 months. ,

    • If defects are wide, repair is often delayed, requiring increased use of presurgical nasal alveolar molding. ,

    • In some cases, surgical procedures may take place into the teenage years, at the end of craniofacial growth period. ,

  • Multidisciplinary approach

    • General pediatrician

    • Plastic, maxillofacial surgery

    • ENT, speech therapy, audiology

    • Orthodontics, dentistry

    • Genetics

    • Feeding evaluation, nutrition consultation

    • Psychological support

Prognosis

  • Surgical results are usually excellent, with most patients achieving aesthetic restoration.

  • Speech development is typically excellent. ,

  • All children require speech and language evaluation annually until 4 years of age.

  • Hearing abnormalities may be identified early, largely related to conduction deafness.

  • Chronic otitis media may become an issue.

  • In some cases, dental abnormalities or poor olfaction can exist, despite repair.

  • Serial cognitive development screening.

  • Recurrence risk of CL±CP

    • If single sibling is affected and no additional family history, up to 4% recurrence risk.

    • If one parent is affected and no additional family history, approximate risk is 4%.

      • 12% if one prior child is also affected and 25% if two children are affected.

    • When both parents are affected, recurrence risk is much higher, ranging from 35% (no prior children affected), to 45% (one child affected), to 50% (two children affected).

Cystic Hygroma

Definition of the Lesion

  • Congenital thin-walled cyst that contains lymphatic fluid.

  • Septated or nonseptated.

  • Can be located throughout the upper body:

    • Soft tissue at the posterior neck region (most common)

    • May extend cephalad to engulf the fetal head

    • May extend caudad to cover the dorsum of the fetus

    • Can be found in the mediastinum and axilla

  • Alternative or historical names for cystic hygroma include cystic lymphangioma, lymphatic hamartoma, jugular lymphatic obstructive sequence, and hygroma cysticum.

Incidence and Pathogenesis

  • Occurs in 1:100 pregnancies in first trimester. The subclassification of septated cystic hygroma occurs in 1:285 pregnancies.

  • Arises from failure of primitive lymphatic tree to connect to the venous system. Blind lymphatic pouch results in dilation of the lymphatic sac.

Key Diagnostic Features

  • Anechoic fluid-filled cavities that are encircled by soft tissue, usually located in the posterior neck.

  • May be multiloculated with septations or simple in appearance.

  • May involve the fetal head, back, axilla, or mediastinum.

  • A thick midline band may be present posteriorly, formed by the nuchal ligament separating the bilateral jugular lymphatic sacs.

Differential Diagnosis

  • Thickened nuchal translucency

  • Neural tube defects (posterior encephalocele, cervical meningocele)

  • Cystic teratoma

  • Hemangioma

  • Thyroglossal duct cysts

  • Branchial cleft cysts

  • Laryngocele

  • Twin-twin transfusion syndrome in monochorionic-diamniotic twin gestations

  • Fetal hydrops

Associated Anomalies

  • Associated structural anomalies are seen in 33.8% of first-trimester cystic hygromas.

  • Aneuploidy (50%)

    • Turner syndrome (28.3%)

    • Trisomy 18 (19.4%)

    • Trisomy 13 (9.0%)

    • Triploidy (4.5%)

    • Mosaic deletion of chromosomes have also been reported

    • When detected while crown-rump length is below 45 mm, lower rates of chromosomal abnormalities and higher proportion of normal birth shiftenteroutcomes

  • Cardiac anomalies

    • Cardiac abnormalities account for 72.7% of the associated structural abnormalities.

    • Reported cardiac anomalies associated with cystic hygroma include hypoplastic left or right heart syndrome, tetralogy of Fallot, ventricular septal defect, and other complex cardiac anomalies.

    • In euploid fetuses, the incidence of major congenital heart disease was 4.3%.

  • Syndromes reported in fetuses with cystic hygroma include Roberts syndrome, Cornelia de Lange syndrome, multiple pterygium syndrome, Noonan syndrome, and fetal akinesia sequence.

  • Skeletal abnormality.

  • Fetal hydrops.

  • Intrauterine fetal demise.

Imaging

Figure 21.7, Fetal Turner syndrome.

Figure 21.8, Thick midline nuchal ligament.

Figure 21.9, Large bilateral cystic mass at the level of the fetal head.

Figure 21.10, Thin septations.

Figure 21.11, Cystic hygroma extending cephalad and caudad.

Figure 21.12, Cystic hygroma with scalp edema.

Figure 21.13, Cystic hygroma in a twin gestation.

Management

Antenatal Monitoring

  • Detailed fetal anatomic survey is necessary to identify potential associated anomalies and to determine the relationship between the hygroma and the upper airway, because obstruction can occur at birth.

  • Fetal echocardiogram should be obtained to evaluate for associated cardiac anomalies.

  • Serial fetal ultrasounds should be performed to evaluate for fetal growth, progression of hygroma, polyhydramnios from esophageal compression, and development of fetal hydrops.

  • Antenatal fetal testing should be considered in late third trimester secondary to the risk of fetal demise.

Obstetric Management

  • Pregnancy termination is an available management option. Fetal autopsy and pathologic examination of fetal and placental tissues may help to establish cause, if unknown.

  • In the patient electing pregnancy continuation, diagnostic genetic testing and fetal echocardiogram are strongly indicated. If karyotype is normal, reflex testing for chromosomal microarray can be considered, because there may be a 5% incremental yield in detection of copy number variants. The most common pathogenic copy number variants reported were 22q11.2 deletion, 22q11.2 duplication, 10q26.12q26.3 deletion, and 12q21q22 deletion. In a series evaluating the utility of whole exome sequencing (WES) in evaluation of fetal hydrops, the incremental yield of WES is reported at 24.3%. Identified pathogenic variants include Noonan syndrome (PTPN11), Costello syndrome (HRAS), cardiofacial cutaneous syndrome (BRAF), thanatophoric dysplasia (FGFR3), Nager acrofacial dysostosis (SF3B4), lymphedema distichiasis (FOXC2), Desanto-Shinawi syndrome (WAC), Mowat-Wilson syndrome (ZEB2), desmosterolosis (DHCR24), Diamond-Blackfan anemia (RPL11), and dehydrated hereditary stomatocytosis (PIEZO1).

  • Antenatal consultations with pediatric subspecialists, neonatologists, and geneticists may be necessary.

  • Fetal MRI may be indicated to distinguish between differential diagnoses and to better delineate anatomic relationship with airway structures, particularly in cases of giant cystic hygromas.

  • If tracheal impingement is suspected or polyhydramnios is present, ex utero intrapartum treatment (EXIT) may allow for establishment of an orotracheal airway or tracheostomy prior to disconnection of the neonate from the uteroplacental vasculature.

Neonatal Management

  • Extensive involvement of airway may be present, requiring management by otolaryngologists, neonatologists, and pediatric surgeons.

  • Thorough evaluation by a pediatrician is indicated.

  • Pterygium colli (webbed neck) may be present.

  • Neonatal evaluation by a geneticist may be necessary to rule out genetic syndromes.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here